259 related articles for article (PubMed ID: 21233315)
1. Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.
Harly C; Peyrat MA; Netzer S; Déchanet-Merville J; Bonneville M; Scotet E
Blood; 2011 Mar; 117(10):2864-73. PubMed ID: 21233315
[TBL] [Abstract][Full Text] [Related]
2. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
3. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function.
Liang S; Zhang W; Horuzsko A
Eur J Immunol; 2006 Sep; 36(9):2457-71. PubMed ID: 16897816
[TBL] [Abstract][Full Text] [Related]
4. Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy.
Barakonyi A; Kovacs KT; Miko E; Szereday L; Varga P; Szekeres-Bartho J
J Immunol; 2002 Mar; 168(6):2683-8. PubMed ID: 11884433
[TBL] [Abstract][Full Text] [Related]
5. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
[TBL] [Abstract][Full Text] [Related]
6. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.
Young NT; Uhrberg M; Phillips JH; Lanier LL; Parham P
J Immunol; 2001 Mar; 166(6):3933-41. PubMed ID: 11238638
[TBL] [Abstract][Full Text] [Related]
8. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
[TBL] [Abstract][Full Text] [Related]
9. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen.
Lafont V; Liautard J; Liautard JP; Favero J
J Immunol; 2001 Jun; 166(12):7190-9. PubMed ID: 11390467
[TBL] [Abstract][Full Text] [Related]
10. Activation of V gamma 9V delta 2 T cells by NKG2D.
Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
[TBL] [Abstract][Full Text] [Related]
11. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
12. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
Cell Immunol; 2002 Jan; 215(1):32-44. PubMed ID: 12142034
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes.
Favier B; Espinosa E; Tabiasco J; Dos Santos C; Bonneville M; Valitutti S; Fournié JJ
J Immunol; 2003 Nov; 171(10):5027-33. PubMed ID: 14607899
[TBL] [Abstract][Full Text] [Related]
14. Recognition of the antigen-presenting molecule MR1 by a Vδ3
Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.
Lesport E; Baudhuin J; Sousa S; LeMaoult J; Zamborlini A; Rouas-Freiss N; Carosella ED; Favier B
Cell Mol Life Sci; 2011 Oct; 68(20):3385-99. PubMed ID: 21337044
[TBL] [Abstract][Full Text] [Related]
16. Skewed inhibitory receptors expression in a TAP2-deficient patient.
Crespí C; Rosa Julià M; Muñoz-Saa I; Pérez-Castellano MT; Milà J; Matamoros N
Immunol Lett; 2003 Apr; 86(2):149-53. PubMed ID: 12644316
[TBL] [Abstract][Full Text] [Related]
17. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
[TBL] [Abstract][Full Text] [Related]
18. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
Mingari MC; Vitale C; Cambiaggi A; Schiavetti F; Melioli G; Ferrini S; Poggi A
Int Immunol; 1995 Apr; 7(4):697-703. PubMed ID: 7547697
[TBL] [Abstract][Full Text] [Related]
19. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
20. Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.
Deniger DC; Maiti SN; Mi T; Switzer KC; Ramachandran V; Hurton LV; Ang S; Olivares S; Rabinovich BA; Huls MH; Lee DA; Bast RC; Champlin RE; Cooper LJ
Clin Cancer Res; 2014 Nov; 20(22):5708-19. PubMed ID: 24833662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
